Top > Search of International Patents > Mass spectrometric analysis of proteins using stable isotopes of pyrylium derivates as labels

Mass spectrometric analysis of proteins using stable isotopes of pyrylium derivates as labels meetings

Foreign code F110002364
Posted date Jan 13, 2011
Country United States of America
Application number 45223308
Gazette No. 20100190261
Gazette No. 8071392
Date of filing Jun 19, 2008
Gazette Date Jul 29, 2010
Gazette Date Dec 6, 2011
International application number JP2008061243
International publication number WO2008156139
Date of international filing Jun 19, 2008
Date of international publication Dec 24, 2008
Priority data
  • P2007-164249 (Jun 21, 2007) JP
  • 2008WO-JP61243 (Jun 19, 2008) WO
Title Mass spectrometric analysis of proteins using stable isotopes of pyrylium derivates as labels meetings
Abstract (US8071392)
The present invention provides a protein analysis method using a combination of two or more kinds of stable isotopes of a compound represented by the formula (I): wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, or a salt thereof, as a labeling compound to produce a difference in the mass of the same kind of protein contained in each sample.
Scope of claims [claim1]
1. A method for determining the quantitative ratio of a target protein contained in two or more kinds of protein-containing samples using a mass spectrometer, which method comprises: (i) providing two or more kinds of protein-containing samples to be analyzed;
(ii) preparing an internal standard sample by preparing starting samples with the same total protein content from all the corresponding protein-containing samples to be analyzed, and mixing equal amounts of the starting samples to obtain the internal standard sample;
(iii) labeling the target protein in each of the protein-containing samples to be analyzed and the internal standard sample with a combination of two or more kinds of stable isotopes of a compound represented by the formula (I):
wherein R1, R2 and R3 are the same or different and each is hydrogen, halogen or alkyl, or a salt thereof having a different mass number due to isotope, thereby producing a difference in the mass of the target protein contained in each of the protein-containing samples and the internal standard sample;
(iv) mixing the respective protein-containing samples and the internal standard sample;
(v) (a) separating the target protein in the mixture obtained in step (iv) from other proteins and cleaving the target protein with a restriction enzyme at a particular amino acid site to give a sample containing isotope-labeled peptides derived from the target protein, or (b) cleaving the target protein in the mixture obtained in step (iv) with a restriction enzyme at a particular amino acid site to give a sample containing isotope-labeled peptides derived from the target protein; and
(vi) measuring an MS spectrum of the isotope-labeled peptides derived from the target protein determining an MS spectral intensity of each of the same kind of peptide derived from the target protein having a mass difference due to isotope labeling, determining the ratios of the MS spectral intensity derived from the protein-containing samples to the MS spectral intensity derived from the internal standard sample, determining the quantitative ratio based on the intensity ratios, and correcting the quantitative ratio by removing the overlap with the isotope peak of the peptide due to naturally occurring isotope.
[claim2]
2. The method of claim 1, wherein the compound of the formula (I) is 2,4,6-trimethyl pyrylium.
[claim3]
3. The method of claim 1, wherein the mass difference between stable isotopes contained in said combination is two or more.
[claim4]
4. The method of claim 1, wherein the mass difference between stable isotopes contained in said combination is four or more.
[claim5]
5. The method of claim 1, wherein the salt of the compound represented by the formula (I) is 2,4,6-trimethyl pyrylium tetrafluoroborate salt, and wherein the mass difference between stable isotopes contained in said combination is 4 or 8.
[claim6]
6. The method of claim 1, wherein the two or more kinds of protein-containing samples comprise (i) samples derived from affected and normal region of tissues, or (ii) samples derived from a certain kind of cell culture in various developmental stages.
[claim7]
7. The method of claim 1, wherein the isotope is 13C isotope.
  • Inventor, and Inventor/Applicant
  • MATSUKAWA SHIGERU
  • FUKUI UNIVERSITY
  • TAIYO NIPPON SANSO
IPC(International Patent Classification)
U.S. Cl./(Sub)
  • G01N033/68A12
  • S01N458/15
Please contact us by E-mail or facsimile if you have any interests on this patent.

PAGE TOP

close
close
close
close
close
close